Vulnerability · Published Aug 22, 2023 · Assigned by mitre
CVE-2022-45611
Critical 9.8
In plain English
A critical-severity security flaw in the affected software. There are no confirmed reports of exploitation so far. The chance it is exploited in the next 30 days is estimated at 1.2% (higher than 68% of all known vulnerabilities).
Severity (CVSS NVD)9.8Critical
Exploit odds (30 days)1.2%top 32.2% of all CVEs
Exploited in the wildNo reportsCISA SSVC: none
Attack toolingNoneno public tooling known
Official description
An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.